-
1.
公开(公告)号:EP3137471A1
公开(公告)日:2017-03-08
申请号:EP15724406.2
申请日:2015-04-29
申请人: Incyte Corporation
发明人: ZHOU, Jiacheng , LIU, Pingli , CHEN, Shili , WU, Yongzhong , WANG, Dengjin , JIA, Zhongjiang , QIAO, Lei , FRIETZE, William , XIA, Michael , DAI, Yingrui
IPC分类号: C07D495/14 , A61K31/437 , A61P25/00 , A61P35/00 , A61P37/00
CPC分类号: C07D495/14 , C07D309/14 , C07D495/04
摘要: This invention relates to processes for preparing a JAK1 inhibitor having Formula Ia: as well as new forms of the inhibitor.
摘要翻译: 本发明涉及用于制备具有式Ia一个JAK1抑制剂:以及所述抑制剂的新形式。
-
公开(公告)号:EP4309737A2
公开(公告)日:2024-01-24
申请号:EP23197192.0
申请日:2019-05-03
申请人: Incyte Corporation
发明人: BURN, Timothy C. , LIU, Phillip C. , FRIETZE, William , JIA, Zhongjiang , TAO, Ming , WANG, Dengjin , ZHOU, Jiacheng , LI, Qun
IPC分类号: A61P35/00
摘要: The present disclosure relates to 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, solid forms and polymorphs thereof, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.
-
公开(公告)号:EP3788047A2
公开(公告)日:2021-03-10
申请号:EP19724676.2
申请日:2019-05-03
申请人: Incyte Corporation
发明人: BURN, Timothy C. , LIU, Phillip C. , FRIETZE, William , JIA, Zhongjiang , TAO, Ming , WANG, Dengjin , ZHOU, Jiacheng , LI, Qun
IPC分类号: C07D471/14 , A61K31/519 , A61P35/00
-
公开(公告)号:EP4010338A1
公开(公告)日:2022-06-15
申请号:EP20760996.7
申请日:2020-08-05
申请人: Incyte Corporation
发明人: JIA, Zhongjiang , FRIETZE, William
IPC分类号: C07D403/12 , A61P35/00 , A61K31/506
-
公开(公告)号:EP3831833A1
公开(公告)日:2021-06-09
申请号:EP20201979.0
申请日:2016-02-26
申请人: Incyte Corporation
发明人: QIAO, Lei , WENG, Lingkai , SHI, ChongSheng Eric , MELONI, David , LIN, Qiyan , XIA, Michael , SHARIEF, Vaqar , FRIETZE, William , JIA, Zhongjiang , PAN, Yongchun , LIU, Pingli , YUE, Tai-Yuen , ZHOU, Jiacheng
IPC分类号: C07D487/04 , A61K31/519 , A61P35/00
摘要: The present application provides processes for preparing ( R )-4-(3-(( S )-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one, which is useful as an inhibitor phosphoinositide 3-kinase-delta (PI3Kδ), as well as a salt form and intermediates related thereto.
-
公开(公告)号:EP3262046A1
公开(公告)日:2018-01-03
申请号:EP16718921.6
申请日:2016-02-26
申请人: Incyte Corporation
发明人: QIAO, Lei , WENG, Lingkai , SHI, ChongSheng Eric , MELONI, David , LIN, Qiyan , XIA, Michael , SHARIEF, Vaqar , FRIETZE, William , JIA, Zhongjiang , PAN, Yongchun , LIU, Pingli , YUE, Tai-Yuen , ZHOU, Jiacheng
IPC分类号: C07D487/04 , A61K31/519 , A61P35/00
摘要: The present application provides processes for preparing (R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo [3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one, which is useful as an inhibitor phosphoinositide 3-kinase-delta (PI3Kδ), as well as a salt form and intermediates related thereto.
-
公开(公告)号:EP4309737A3
公开(公告)日:2024-03-27
申请号:EP23197192.0
申请日:2019-05-03
申请人: Incyte Corporation
发明人: BURN, Timothy C. , LIU, Phillip C. , FRIETZE, William , JIA, Zhongjiang , TAO, Ming , WANG, Dengjin , ZHOU, Jiacheng , LI, Qun
IPC分类号: C07D471/14 , A61K31/519 , A61P35/00
摘要: The present disclosure relates to 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, solid forms and polymorphs thereof, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the FGFR-associated or mediated diseases such as cancer.
-
公开(公告)号:EP3262046B1
公开(公告)日:2020-11-04
申请号:EP16718921.6
申请日:2016-02-26
申请人: Incyte Corporation
发明人: QIAO, Lei , WENG, Lingkai , SHI, ChongSheng Eric , MELONI, David , LIN, Qiyan , XIA, Michael , SHARIEF, Vaqar , FRIETZE, William , JIA, Zhongjiang , PAN, Yongchun , LIU, Pingli , YUE, Tai-Yuen , ZHOU, Jiacheng
IPC分类号: C07D487/04 , A61K31/519 , A61P35/00
-
公开(公告)号:EP3334709A1
公开(公告)日:2018-06-20
申请号:EP16754092.1
申请日:2016-08-11
申请人: Incyte Corporation
发明人: LI, Qun , PAN, Yongchun , HAN, Wayne , CAO, Ganfeng , FRIETZE, William , JIA, Zhongjiang , SHARIEF, Vaqar , ZHOU, Jiacheng
IPC分类号: C07D211/26 , C07D211/32 , A61K31/44
CPC分类号: C07D211/26 , C07D211/22 , C07D211/32
摘要: The present disclosure relates to tosylate salts 1-{[4-(methoxymethyl)-4-({[(1R,2S)-2-phenylcyclopropyl]amino}methyl)piperidin-1-yl]methyl}cyclobutanecarboxylic acid, methods of preparation thereof, and intermediates in the preparation thereof, which are useful in the treatment of the LSD1-associated or mediated diseases such as cancer.
-
-
-
-
-
-
-
-